Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Resting heart rate as a tool for risk stratification in primary care: does it provide incremental prognostic information?

Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT-Study Group..

Eur J Prev Cardiol. 2012 Apr;19(2):275-84. doi: 10.1177/1741826710394304. Epub 2011 Feb 18.

PMID:
21450610
2.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
4.

Heart rate and the cardiometabolic risk.

Palatini P.

Curr Hypertens Rep. 2013 Jun;15(3):253-9. doi: 10.1007/s11906-013-0342-7. Review.

PMID:
23645136
5.

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC.

Can J Cardiol. 2008 May;24 Suppl A:3A-8A. Review.

6.

Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand?

Menown IB, Davies S, Gupta S, Kalra PR, Lang CC, Morley C, Padmanabhan S.

Cardiovasc Ther. 2013 Aug;31(4):215-23. doi: 10.1111/j.1755-5922.2012.00321.x. Review.

7.

Heart rate as a risk factor for cardiovascular disease.

Perret-Guillaume C, Joly L, Benetos A.

Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):6-10. doi: 10.1016/j.pcad.2009.05.003. Review.

PMID:
19615487
8.

[The resting heart rate].

Bemelmans RH, Visseren FL.

Ned Tijdschr Geneeskd. 2014;158:A6931. Review. Dutch.

PMID:
24666528
9.

Elevated heart rate: a "new" cardiovascular risk factor?

Palatini P.

Prog Cardiovasc Dis. 2009 Jul-Aug;52(1):1-5. doi: 10.1016/j.pcad.2009.06.001. Review.

PMID:
19615486
10.

Heart rate as a possible therapeutic guide for the prevention of cardiovascular disease.

Inoue T, Iseki K, Ohya Y.

Hypertens Res. 2013 Oct;36(10):838-44. doi: 10.1038/hr.2013.98. Epub 2013 Aug 22. Review.

PMID:
23966053
11.

[Job strain and heart rate variability. New evidence and new prospects].

Borchini R, Ferrario MM.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):174-6. Review. Italian.

PMID:
23405612
12.

Heart rate variability and the metabolic syndrome: a systematic review of the literature.

Stuckey MI, Tulppo MP, Kiviniemi AM, Petrella RJ.

Diabetes Metab Res Rev. 2014 Nov;30(8):784-93. doi: 10.1002/dmrr.2555. Review.

PMID:
24816921
13.

[The best of epidemiology and cardiovascular prevention in 2005].

Thomas D, Cambou JP, Zeller M, Danchin N, Empana JP, Ferrières J, Jouven X, Paillard F, Valensi P, Cottin Y; Groupe Epidémiologie et Prévention de la Société Française de Cardiologie.; Societe Française de Cardiolgie..

Arch Mal Coeur Vaiss. 2006 Jan;99 Spec No 1(1):49-56. Review. French.

PMID:
16479964
14.

[Heart rate and cardiovascular risk].

César LA.

Rev Assoc Med Bras (1992). 2007 Sep-Oct;53(5):456-9. Review. Portuguese.

15.

Independent prognostic value of MRI beyond existing methods of determining cardiovascular risk - is there a role?

Langhans B, Hausleiter J, Bamberg F.

Expert Rev Cardiovasc Ther. 2014 Jan;12(1):13-6. doi: 10.1586/14779072.2014.865518. Epub 2013 Dec 2. Review.

PMID:
24308810
16.

Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations.

Boudoulas KD, Borer JS, Boudoulas H.

Cardiology. 2015;132(4):199-212. doi: 10.1159/000435947. Epub 2015 Aug 15. Review.

17.

[Simulation of a risk for cardiovascular diseases and their events at individual and group levels].

Boitsov SA, Shal'nova SA, Deev AD, Kalinina AM.

Ter Arkh. 2013;85(9):4-10. Review. Russian.

PMID:
24261223

Supplemental Content

Support Center